Clinical Trials Directory

Trials / Completed

CompletedNCT04898673

CP1110 Sound Processor Feasibility

A Pre-Marketing, Prospective, Multi-Site, Open-Label, Within-Subject, Feasibility, Interventional Study of Speech Perception With Experienced Adult Cochlear Implant Recipients Using the CP1110 Sound Processor and Compared With the CP1000 Sound Processor

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Cochlear · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The clinical study aims to investigate the speech performance with the CP1110 Sound Processor, compared with the CP1000 Sound Processor, and inclusion of a noise reduction feature in the Automatic Scene Classifier..

Detailed description

The study will build on the evidence previously collected on behind-the-ear sound processors and noise reduction, with particular focus on the speech perception performance of the CP1110 Sound Processor when compared to the CP1000 Sound Processor. To assess the primary and secondary speech perception objectives, the study incorporates a within-subject repeated-measures design in which each subject will undergo in-booth speech perception testing with all combinations of hardware and signal processing settings in a sound booth. The average difference scores will indicate the performance difference for each of the paired comparisons.

Conditions

Interventions

TypeNameDescription
DEVICECP1110Sound Processor
DEVICECP1000Sound Processor

Timeline

Start date
2021-10-25
Primary completion
2021-12-16
Completion
2021-12-16
First posted
2021-05-24
Last updated
2025-02-11
Results posted
2024-08-12

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT04898673. Inclusion in this directory is not an endorsement.